Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report

BACKGROUND: Pembrolizumab is a humanized monoclonal antibody which serves to enhance the antitumor immune response by targeting programmed cell death 1 receptor. The use of pembrolizumab plus carboplatin/pemetrexed combination therapy results in improvement in overall survival and progression-free s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Oncol
Hlavní autoři: Fakhri, Ghina, Akel, Reem, Salem, Ziad, Tawil, Ayman, Tfayli, Arafat
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836160/
https://ncbi.nlm.nih.gov/pubmed/29515398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000484596
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky